LOS ANGELES – As the greater Los Angeles area continues to be hamstrung by an opioid epidemic that has seen approximately 500 overdose deaths this year, the DEA in Los Angeles has announced a new comprehensive opioid strategy. At a press conference on Dec. 18, 2018, the DEA in Los...

WASHINGTON – The Drug Enforcement Administration today announced action against a dangerous designer synthetic cathinone linked to 151 overdose deaths in the United States between 2015 and 2018. Published in today’s Federal Register, DEA’s action puts N-Ethylpentylone into Schedule I of the Controlled Substances Act. Schedule I substances refer to...

WASHINGTON – The Department of Justice and U.S. Drug Enforcement Administration have proposed a reduction for controlled substances that may be manufactured in the U.S. next year. Consistent with President Trump’s “Safe Prescribing Plan” that seeks to “cut nationwide opioid prescription fills by one-third within three years,” the proposal decreases...